DiaMonTech Publishes Results of Clinical Trial in Springer Communications Medicine
BERLIN, 9th of FEBRUARY 2026
In a prospective, blinded study published in “Springer Nature Communications Medicine", DiaMonTech has demonstrated for the first time that a fully non-invasive, laser-based approach can achieve a level comparable to that of commercially approved devices.
CEO Thorsten Lubinski comments: “It all started with a prototype the size of a refrigerator. Today, we’re working on a portable device as small as a cell phone. The study’s results are a crucial step toward pain-free, reliable blood glucose monitoring.”
We’re thrilled to share this milestone with our community and are grateful to everyone who helped make it possible!
